Jim Cramer broke down moves in Constellation Brands and its link to Washington D.C. » Read More
Jim Cramer says hedge fund managers that call a top to the stock market are never sorry and never own up to calling it early. » Read More
Jim Cramer puts GNC and Vitamin Shoppe to the test to find out why the stocks have been such a train wreck. » Read More
By: Luqman Adeniyi
The "Fast Money" traders said the confusion over White House support for a border adjustment tax creates a profitable environment for some stocks. » Read More
Equinix fell after CFO Keith Taylor said smaller companies are gaining market share in the data center business.
After many false starts, we're finally starting to see the IPO market gain ground in September.
Shares of Sarepta Therapeutics jumped more than 13 percent in Tuesday trade after closing higher Monday on government approval of its drug.
Ascena Retail Group plummeted after it missed its fourth quarter profit forecasts, which follows a loss in the same period last year.
The "Fast Money" traders share their first moves for the market open.
Jim Cramer has noticed a secret pattern behind the price of oil, and goes step by step to reveal how it works.
Jim Cramer highlights one of the best oil moves he has ever seen.
Jim Cramer found the one stock that is not connected to the Federal Reserve that could go on a run regardless of what happens Wednesday.
The "Fast Money" traders debated how investors should position their portfolios ahead of two major central bank meetings.
Stocks of companies in the same industry groups are starting to move in lockstep — a sign to some strategists that stocks will go higher.
Deutsche Bank told clients which stocks to buy if Trump or Clinton gets elected.
Apple's shares are slipping on Monday, but trader Todd Gordon sees a big opportunity to make money on the tech giant's next move.
Wynn Resorts fell as much as 4 percent Monday after researcher Nomura cited mass-market softness at the company's recently opened Macau property.
Jim Lebenthal, who's up 31 percent this year in his CNBC PRO model portfolio, sells Apple.
Stocks have a lot of runway to put up gains as investors chase high-performing equities and seasonal strength kicks in, Tom Lee said.
Wells Fargo's $185 million settlement, and Mylan's EpiPen mess were about corporate greed, the Aspen Institute CEO says.
Baird raises its rating for Wells Fargo to outperform from neutral.
Jim Cramer fired back on critics who claimed that Apple's iPhone 7 sales wouldn't be as good, if Samsung didn't have its Galaxy Note 7 recall.
The bank’s scandal won’t have meaningful effect on its balance sheet, Baird analysts say.
Shares of Sarepta Therapeutics briefly surge after the FDA approved its muscular dystrophy drug eteplirsen.
Get the best of CNBC in your inbox